US Broker Ratings

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 58% Upside Potential Amid Strong Revenue Growth

For investors seeking opportunities in the healthcare sector, Alignment Healthcare, Inc. (ALHC) presents a compelling case with its impressive revenue growth and significant upside potential. The..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Impressive Return on Equity and a Promising Upside

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) presents a compelling case. With its significant upside potential and a remarkable return..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 102.68% Potential Upside in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology firm, is at the forefront of revolutionizing drug discovery through its integration of technological innovations across biology, chemistry,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 156.84% Potential Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is emerging as a compelling opportunity in the healthcare sector, particularly for investors with an appetite for biotech stocks. With a..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Valuation with Promising Upside

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, specializes in medical devices that enhance the analysis of biological systems. With a market..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 69% Potential Upside in the Biotech Arena

ImmunityBio, Inc. (NASDAQ: IBRX), a San Diego-based biotechnology firm, is making waves in the healthcare sector with its pioneering approach to immunotherapy. As the company focuses..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 17% Potential Upside in the Biotech Sector

Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of biotechnology innovation, with a focus on manufacturing and selling synthetic DNA-based products. As the healthcare sector..

Agios Pharmaceuticals (AGIO) Stock Analysis: 31.81% Potential Upside Sparks Investor Interest

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing opportunity for investors focused on the healthcare sector, particularly the biotechnology industry. With a market capitalization of $2.08..

NovoCure Limited (NVCR): Stock Analysis Reveals 80% Potential Upside Amidst Innovative Cancer Treatment Strategies

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the healthcare sector, operates within the medical devices industry and is headquartered in Baar, Switzerland. With a market..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Uncovering a 72.85% Potential Upside Amidst High Growth

For investors with an eye on the healthcare sector, Establishment Labs Holdings Inc (NASDAQ: ESTA) presents an intriguing opportunity with its focus on innovative medical devices..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating the Biotech Frontier with a Market Cap of $10.22 Billion

Apogee Therapeutics, Inc. (APGE) has emerged as a notable player in the biotechnology sector, marked by its impressive market capitalization of $10.22 billion. As a subsidiary..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 31.44% Upside Potential Amid Market Challenges

Novavax, Inc. (NASDAQ: NVAX) has been a focal point in the biotechnology sector, especially with its involvement in the development of vaccines for infectious diseases. As..

Edgewise Therapeutics (EWTX) Stock Analysis: Uncovering a 38.75% Upside with Strong Buy Ratings

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing investors’ attention in the healthcare sector with an intriguing blend of innovation and potential upside. As a biopharmaceutical company..

Veracyte, Inc. (VCYT) Stock Analysis: 33% Potential Upside Beckons Investors

Veracyte, Inc. (VCYT), a leading player in the diagnostics and research sector, stands at an intriguing crossroads for investors, offering a compelling 33.37% potential upside based..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 30% Potential Upside

Teladoc Health, Inc. (TDOC) has carved a niche in the burgeoning healthcare sector by offering virtual healthcare services, a market that has gained significant traction in..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Evaluating Growth Potential Amid a 10.30% Return on Equity

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) has positioned itself as a significant player in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing...

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 66% Potential Upside Amid Biotech Growth

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investor attention with a promising potential upside of 66.03%, as suggested by analyst..

Janux Therapeutics (JANX): Biotechnology Innovator with 116% Potential Upside

Janux Therapeutics, Inc. (NASDAQ: JANX) is an emerging player in the biotechnology sector, capturing investor attention with its innovative approach to cancer treatment and a striking..

Neogen Corporation (NEOG) Stock Analysis: Exploring a Potential 20% Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG), a pivotal player in the healthcare sector’s medical devices industry, is garnering significant attention from investors due to its promising growth prospects..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Navigating the Healthcare Sector with Non-Opioid Solutions

Pacira BioSciences, Inc. (NASDAQ: PCRX) is making its mark in the healthcare sector as a significant player in non-opioid pain management and regenerative health solutions. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds